Association between -251A>T polymorphism in the interleukin-8 gene and oral cancer risk: A meta-analysis

Gene

Volumn 522, Issue 2, 2013, Pages 168-176

  Wang, Zhiming ^a   Wang, Chuanning ^a   Zhao, Zhiguo ^a   Liu, Fang ^a   Guan, Xinming ^a   Lin, Xiaoping ^a   Zhang, Liping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 8; Meta analysis; Oral cancer; Single nucleotide polymorphisms

Indexed keywords

INTERLEUKIN 8;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; META ANALYSIS (TOPIC); MOUTH CANCER; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-8; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84878112741     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.066     Document Type: Article

References (34)

1. Agaku I.T., Akinyele A.O. Comparison of external beam radiation therapy and radioactive implants in the management of nonmetastatic oral squamous cell cancer: an analysis of the surveillance epidemiology and end results database. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2012, 115(1):38-45. (PMID:23021918).
2. Anantharaman D., Chaubal P.M., Kannan S., Bhisey R.A., Mahimkar M.B. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 2007, 28(7):1455-1462. (PMID:17307803).
3. Ayllon Barbellido S., Campo Trapero J., Cano Sanchez J., Perea García M.A., Escudero Castaño N., Bascones Martínez A. Gene therapy in the management of oral cancer: review of the literature. Med. Oral Patol. Oral Cir. Bucal 2008, 13(1):E15-E21. (PMID:18167474).
4. Bidwell J., et al. Cytokine gene polymorphism in human disease: on-line data-bases, supplement 1. Genes Immun. 2001, 2(2):61-70. (PMID: 11393658).
5. Bo S., Dianliang Z., Hongmei Z., Xinxiang W., Yanbing Z., Xiaobo L. Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. J. Interferon Cytokine Res. 2010, 30(1):9-14. (PMID:19929572).
6. Campa D., et al. Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Cancer Causes Control 2007, 18(4):449-455. (PMID:17356794).
7. da Costa B.R., Cevallos M., Altman D.G., Rutjes A.W., Egger M. Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 2011, 1(1):e000048. (PMID: 22021739).
8. Fowke J.H., et al. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev. 2004, 13(8):1308-1315. (PMID:15298951).
9. Han S., et al. Epidemiology and cost analysis for patients with oral cancer in a university hospital in China. BMC Public Health 2010, 10:196. (PMID:20398380).
10. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. (Mar 4, PMID: 21376230).
11. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21(11):1539-1558. (PMID: 12111919).
12. Hu Y., et al. IL-8-251 single nucleotide polymorphism in the recurrence of squamous cell carcinoma of tongue. J. Pract. Stomatol. 2012, 28(3):328-332.
13. Hull J., Thomson A., Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000, 55(12):1023-1027. (Dec, PMID: 11083887).
14. Hull J., et al. Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum. Genet. 2004, 114(3):272-279. (PMID:14605870).
15. Hussain S.P., Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 2007, 121(11):2373-2380. (Dec 1, PMID: 17893866).
16. Kietthubthew S., Wickliffe J., Sriplung H., Ishida T., Chonmaitree T., Au W.W. Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int. J. Hyg. Environ. Health 2010, 213(2):146-152. (Mar, PMID: 20133197).
17. Lambert R., Sauvaget C., de Camargo Cancela M., Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur. J. Gastroenterol. Hepatol. 2011, 23(8):633-641. (PMID:21654320).
18. Liu L., Zhuang W., Wang C., Chen Z., Wu X.-T., Zhou Y. Interleukin-8-251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. Cytokine 2010, 50(3):328-334. (PMID:20363644).
19. Liu C.M., et al. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Oral Dis. 2012, 18(3):307-314. (Apr, PMID: 22151543).
20. Mustapha M.A., Shahpudin S.N., Aziz A.A., Ankathil R. Risk modification of colorectal cancer susceptibility by interleukin-8-251T>A polymorphism in Malaysians. World J. Gastroenterol. 2012, 18(21):2668-2673. (PMID:22690076).
21. Okada R., et al. Interleukin-8 T-251A polymorphism was associated with positive anti-p53 antibodies in Uzbekistan population. Nagoya J. Med. Sci. 2009, 71(3-4):151-156. (PMID: 19994728).
22. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295(6):676-680. (PMID: 16467236).
23. Shi Q., Abbruzzese J.L., Huang S., Fidler I.J., Xiong Q., Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin. Cancer Res. 1999, 5(11):3711-3721. (Nov, PMID: 10589791).
24. Shimizu Y., Kondo S., Shirai A., Furukawa M., Yoshizaki T. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 2008, 35(3):381-389. (Sep, PMID: 18276095).
25. Supic G., Jovic N., Zeljic K., Kozomara R., Magic Z. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. Oral Oncol. 2012, 48(11):1171-1177. (PMID:22818823).
26. Taniyama Y., Takeuchi S., Kuroda Y. Genetic polymorphisms and oral cancer. J. UOEH 2010, 32(3):221-236. (PMID:20857816).
27. Vairaktaris E., et al. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur. J. Surg. Oncol. 2007, 33(4):504-507. (PMID:17174061).
28. Vairaktaris E., et al. Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2008, 134(8):821-832. (PMID:18273643).
29. Warnakulasuriya S. Livingwith oral cancer: epidemiologywith particular reference to prevalence and life-style changes that influence survival. Oral Oncol. 2010, 46(6):407-410. (PMID:20403722).
30. Xu W.H., et al. Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women. Am. J. Epidemiol. 2011, 173(8):923-931. (PMID:21382839).
31. Xue H., Liu J., Lin B., Wang Z., Sun J., Huang G. A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk. PLoS One 2012, 7(1):e28083. (PMID:22279522).
32. Zhang X.Y., Zhou D.F., Cao L.Y., Zhang P.Y., Wu G.Y., Shen Y.C. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J. Clin. Psychiatry 2004, 65(7):940-947. (Jul, PMID: 15291683).
33. Zini A., Czerninski R., Sgan-Cohen H.D. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J. Oral Pathol. Med. 2010, 39(4):299-305. (PMID:20040019).
34. Zintzaras E., Ioannidis J.P. Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 2005, 28(2):123-137. (PMID: 15593093).